Incidence and Risk of Intestinal and Extra-intestinal Complications in Medicaid Patients with Inflammatory Bowel Disease: A 5-Year Population-Based Study
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background and Aim
Intestinal and extra-intestinal complications are associated with inflammatory bowel disease (IBD) but their exact incidence is not well known. In order to improve our understanding of their incidence and impact, we assessed the complications associated with ulcerative colitis (UC) and Crohn’s disease (CD) in a population-based study in Medicaid patients.
We utilized a retrospective cohort design and identified cases of UC and CD using Medi-Cal, the Medicaid program for the State of California. The disease cohort was age- and gender-matched to four controls each and the intestinal and extra-intestinal complications of CD and UC (analyzed separately) were studied over a period of 5 years following the initial diagnosis.
For UC, the total number of intestinal complications, per 100 cases, was 92 observed compared to 21 expected; the total number of extra-intestinal complications was 42 observed compared to 30 expected. For CD, the number of intestinal complications was 81 observed compared to 20 expected and for extra-intestinal complications, 37 observed compared to 26 expected (all p < 0.001). For both UC and CD, bleeding was the most frequently seen intestinal complication, while the most common extra-intestinal complication was osteoporosis.
IBD is associated with several intestinal and extra-intestinal complications of variable incidence and risk. Success of therapeutic regimens should be measured by decreases in incidence, risks, and costs of these complications, in addition to the usual impact on disease activity.
- Podolsky, DK (2002) Inflammatory bowel disease. N Engl J Med 347: pp. 417-429 CrossRef
- National Institute of Diabetes and Digestive and Kidney Diseases. Digestive Diseases in the United States: Epidemiology and Impact. Washington, DC: US Government Printing Office. In; 1994 NIH publication 94–1447.
- American Gastroenterological Association. The burden of gastrointestinal diseases. http://www.gastro.org/user-assets/Documents/burden-report.pdf; 1998 Accessed September 10, 2007.
- Farmer, RG, Hawk, WA, Turnbull, RB (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68: pp. 627-635
- Greenstein, AJ, Janowitz, HD, Sachar, DB (1976) The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 55: pp. 401-412 CrossRef
- Monsen, U, Sorstad, J, Hellers, G, Johansson, C (1990) Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol 85: pp. 711-716
- Rankin, GB, Watts, HD, Melnyk, CS, Kelley, ML (1979) National Cooperative Crohn’s Disease study: extraintestinal manifestations and perianal complications. Gastroenterology 77: pp. 914-920
- Veloso, FT, Carvalho, J, Magro, F (1996) Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 23: pp. 29-34 CrossRef
- Crohn’s & Colitis Foundation of America. http://www.ccfa.org; Accessed October 12, 2007.
- California Department of Health Services. Medi-Cal facts and figures. www.chcf.org/documents/policy/MediCalFactsAndFigures2006.pdf; Accessed February 2, 2008.
- California Department of Health Services. Medi-Cal payment error study. California Department of Health Services. http://www.dhs.ca.gov/ane/PDF/MPES%20and%20PAM%2001052005.pdf; 2004 Accessed May 17, 2007.
- Parc, R, Roger, V, Penna, C Management of hemorrhage. In: Michelassi, F, Milsom, JW eds. (1999) Operative strategies in inflammatory bowel disease. Springer, New York, pp. 229-233
- Robert, JR, Sachar, DB, Greenstein, AJ (1991) Severe gastrointestinal hemorrhage in Crohn’s disease. Ann Surg 213: pp. 207-211 CrossRef
- Robert, JH, Sachar, DB, Aufses, AH, Greenstein, AJ (1990) Management of severe hemorrhage in ulcerative colitis. Am J Surg 159: pp. 550-555 CrossRef
- Jahnsen, J, Falch, JA, Mowinckel, P, Aadland, E (2004) Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol 39: pp. 145-153 CrossRef
- Schulte, C, Dignass, AU, Mann, K, Goebell, H (1998) Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 4: pp. 268-275 CrossRef
- Jahnsen, J, Falch, JA, Aadland, E, Mowinckel, P (1997) Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population-based study. Gut 40: pp. 313-319
- Silvennoinen, JA, Karttunen, TJ, Niemela, SE, Manelius, JJ, Lehtola, JK (1995) A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 37: pp. 71-76 CrossRef
- Bargiggia, S, Maconi, G, Elli, M (2003) Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J Clin Gastroenterol 36: pp. 417-420 CrossRef
- Kratzer, W, Haenle, MM, Mason, RA, Tirpitz, C, Kaechele, V (2005) Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease. World J Gastroenterol 11: pp. 6170-6175
- Fraquelli, M, Losco, A, Visentin, S (2001) Gallstone disease and related risk factors in patients with Crohn's disease: analysis of 330 consecutive cases. Arch Intern Med 161: pp. 2201-2204 CrossRef
- Orchard, TR, Wordsworth, BP, Jewell, DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42: pp. 387-391 CrossRef
- Salvarani, C, Vlachonikolis, IG, Heijde, DM (2001) Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36: pp. 1307-1313 CrossRef
- Bernstein, CN, Blanchard, JF, Rawsthorne, P, Yu, N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96: pp. 1116-1122 CrossRef
- Jess, T, Gamborg, M, Matzen, P, Munkholm, P, Sorensen, TI (2005) Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100: pp. 2724-2729 CrossRef
- Eaden, JA, Abrams, KR, Mayberry, JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: pp. 526-535 CrossRef
- Kappelman, MD, Rifas-Shiman, SL, Kleinman, K (2007) The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5: pp. 1424-1429 CrossRef
- Incidence and Risk of Intestinal and Extra-intestinal Complications in Medicaid Patients with Inflammatory Bowel Disease: A 5-Year Population-Based Study
Digestive Diseases and Sciences
Volume 55, Issue 6 , pp 1689-1695
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Inflammatory bowel disease
- Crohn’s disease
- Ulcerative colitis
- Industry Sectors
- Author Affiliations
- 1. Division of Gastroenterology, Hepatology and Nutrition, University of Texas Medical School, Houston, TX, USA
- 2. Division of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center, Houston, TX, USA
- 3. Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Always Building, Room M 211, 300 Pasteur Drive, MC: 5187, Stanford, CA, 94305-5187, USA
- 4. Institute of Clinical Outcomes Research and Education, Palo Alto, CA, USA